Curis reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 57.3B 19M Jun/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Eli Lilly USD 54.91B 11.54B Jun/2026
Exelixis USD 162.2M 3.73M Sep/2026
Gilead Sciences USD 26.25B 4.07B Jun/2026
GlaxoSmithKline GBP 18.24B 818M Jun/2026
Incyte USD 38.27M 1.16M Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 62.67B 523M Sep/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
Takeda JPY 4.58T 364.32B Sep/2026
TG Therapeutics USD 754.37M 68K Sep/2026
Verastem USD 66.79M 26.7M Sep/2024